Publikationen von Bellinda Lantzberg

Lantzberg, B.; Zeyn, Y.; Forster, R.; Lin, J.; Schauenburg, D.; Hieber, C.; Nuhn, L.; Zhou, T.; Silva, M. J.S.A.; Koynov, K. et al.; Jiang, H.-L.; Kuan, S. L.; Bros, M.; Opatz, T.; Weil, T.: Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver. Journal of Controlled Release 382, 113705 (2025)

Heck, A.; Schwiertz, D.; Lantzberg, B.; Nguyen, H.-C.; Forster, R.; Scherger, M.; Opatz, T.; Ginderachter, J. A. V.; Nuhn, L.: Introducing Targeting Units or pH-Releasable Immunodrugs into Core-Clickable Nanogels. European Polymer Journal 214, 113150 (2024)

Fuchs, N.; Meta, M.; Lantzberg, B.; Bros, M.; Kuan, S. L.; Weil, T.; Schirmeister, T.: Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible alpha-Fluorovinylsulfones and alpha-Sulfonates as Potential Immunomodulators in Cancer. ChemMedChem 18 (15), e202300160 (2023)

Zegota, M. M.; Müller, M.; Lantzberg, B.; Kizilsavas, G.; Coelho, J. A. S.; Moscariello, P.; Martínez Negro, M.; Morsbach, S.; Gois, P. M. P.; Wagner, M. et al.; Ng, D. Y. W.; Kuan, S. L.; Weil, T.: Dual Stimuli-Responsive Dynamic Covalent Peptide Tags: Toward Sequence-Controlled Release in Tumor-like Microenvironments. Journal of the American Chemical Society 143 (41), S. 17047 - 17058 (2021)